Literature DB >> 20674894

Angiotensin-(1-7), its receptor Mas, and the angiotensin-converting enzyme type 2 are expressed in the human ovary.

Fernando M Reis1, Daniela R Bouissou, Virginia M Pereira, Aroldo F Camargos, Adelina M dos Reis, Robson A Santos.   

Abstract

OBJECTIVE: To investigate whether angiotensin (Ang)-(1-7), its receptor Mas, and angiotensin-converting enzyme type 2 (ACE2) are present in human ovary.
DESIGN: Cross-sectional study.
SETTING: Academic hospital. PATIENT(S): Twelve reproductive-age women and five postmenopausal women undergoing oophorectomy for nonovarian diseases and seven women having controlled ovarian hyperstimulation for IVF. INTERVENTION(S): Ovarian tissue was obtained from the reproductive-age women and postmenopausal women undergoing oophorectomy for nonovarian diseases. Follicular fluid (FF) samples were obtained from the women having controlled ovarian hyperstimulation for IVF. MAIN OUTCOME MEASURE(S): Localization of Ang-(1-7) and Mas by immunohistochemistry; measurement of Ang-(1-7) in ovarian FF by RIA; detection of messenger RNAs encoding Mas and ACE2 with use of real-time polymerase chain reaction; assessment of 125I-labeled Ang-(1-7) binding to ovarian sections with use of autoradiographic binding assay. RESULT(S): Angiotensin-(1-7) and the receptor Mas were localized to primordial, primary, secondary, and antral follicles, stroma, and corpora lutea of reproductive-age ovaries. Postmenopausal women expressed both the peptide and its receptor in the ovarian stroma. Angiotensin-(1-7) was detectable in FF (mean±SE: 191±54 pg/mL). Both Mas and ACE2 messenger RNAs were expressed in ovarian tissue, as revealed by real-time polymerase chain reaction, and ovarian binding sites for 125I-labeled Ang-(1-7) were identified by autoradiography. CONCLUSION(S): Angiotensin-(1-7), its receptor Mas, and ACE2 are expressed in the human ovary. The peptide is present in several ovarian compartments and can be quantified in FF.
Copyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20674894     DOI: 10.1016/j.fertnstert.2010.06.060

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  47 in total

Review 1.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

2.  MAS promoter regulation: a role for Sry and tyrosine nitration of the KRAB domain of ZNF274 as a feedback mechanism.

Authors:  Jeremy W Prokop; Frank J Rauscher; Hongzhuang Peng; Yuanjie Liu; Fabiano C Araujo; Ingrid Watanabe; Fernando M Reis; Amy Milsted
Journal:  Clin Sci (Lond)       Date:  2014-05       Impact factor: 6.124

3.  Angiotensin converting enzyme 2 abrogates bleomycin-induced lung injury.

Authors:  G J Rey-Parra; A Vadivel; L Coltan; A Hall; F Eaton; M Schuster; H Loibner; J M Penninger; Z Kassiri; G Y Oudit; B Thébaud
Journal:  J Mol Med (Berl)       Date:  2012-01-14       Impact factor: 4.599

Review 4.  The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).

Authors:  Robson Augusto Souza Santos; Walkyria Oliveira Sampaio; Andreia C Alzamora; Daisy Motta-Santos; Natalia Alenina; Michael Bader; Maria Jose Campagnole-Santos
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

Review 5.  Potential effects of COVID-19 on reproductive health: a mini review.

Authors:  Xiao-Dong Mao; Kang-Sheng Liu; Yan-Ping Yao; Zhi-Rong Xu
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

6.  THE ROLE OF HIGH FOLLICULAR LEVELS OF ANGIOTENSIN II AND VASCULAR ENDOTHELIAL GROWTH FACTOR IN ANTICIPATING THE DEVELOPMENT OF SEVERE OVARIAN HYPERSTIMULATION SYNDROME IN PATIENTS WITH PROPHYLACTIC CABERGOLINE THERAPY UNDERGOING AN IN VITRO FERTILIZATION PROCEDURE.

Authors:  M Surcel; M Surcel; C Zlatescu-Marton; R Micu; G I Nemeti; D D Axente; C Mirza; I Neamtiu
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Jan-Mar       Impact factor: 0.877

Review 7.  Effects of SARS-CoV-2 infection on human reproduction.

Authors:  Ming Yang; Jing Wang; Yidong Chen; Siming Kong; Jie Qiao
Journal:  J Mol Cell Biol       Date:  2021-12-30       Impact factor: 6.216

8.  Does mRNA SARS-CoV-2 vaccine influence patients' performance during IVF-ET cycle?

Authors:  Raoul Orvieto; Meirav Noach-Hirsh; Aliza Segev-Zahav; Jigal Haas; Ravit Nahum; Adva Aizer
Journal:  Reprod Biol Endocrinol       Date:  2021-05-13       Impact factor: 5.211

9.  Investigating the impact of asymptomatic or mild SARS-CoV-2 infection on female fertility and in vitro fertilization outcomes: A retrospective cohort study.

Authors:  Meng Wang; Qiyu Yang; Xinling Ren; Juan Hu; Zhou Li; Rui Long; Qingsong Xi; Lixia Zhu; Lei Jin
Journal:  EClinicalMedicine       Date:  2021-07-06

10.  Angiotensin-converting enzyme 2, the SARS-CoV-2 cellular receptor, is widely expressed in human myometrium and uterine leiomyoma.

Authors:  Alexon M Racilan; Wiviane A Assis; Maíra Casalechi; Ananda Spagnolo-Souza; Marcelo A Pascoal-Xavier; Ana C Simões-E-Silva; Helen L Del Puerto; Fernando M Reis
Journal:  J Endometr Pelvic Pain Disord       Date:  2021-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.